BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript
BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56.
Source: insidermonkey.com
Waterlase Trial Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Waterlase Trial Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Waterlase Trial Program Today - Breaking & Trending Today
BIOLASE, Inc. (NASDAQ:BIOL) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the BIOLASE Second Quarter 2023 Financial Results Conference Call. Please note this call is being recorded.
Source: insidermonkey.com
BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the second quarter ended June 30,...
Source: prnewswire.com